Milestone Pharmaceuticals Inc.

MIST | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.92

$0 (+0.46%)

At close: Sep 21, 2026, 4:00 PM ET

$0.92

$0 (-0.24%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.46%

(1D)

Rating

Updated: Sep 18, 2026

36.5

Fundamentals Average

Market Sentiment Bearish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $114.26M

1D Range

0.90 0.93

52W Range

0.88 3.06

Valuation (TTM)

PE -1.33

PB 6.27

EV/EBITDA -0.05

Valuation (NTM)

Forward PE N/A

Forward PEG 1.31

Price Target $4.50

Cash Flow

FCF Yield -33.8%

SBC Adj. FCF Yield -40.8%

SBC Impact -20.6%

Margins

Gross Margin 94.6%

Operating Margin -3353.0%

FCF Margin -1649.9%

Growth (CAGR)

Revenue 3Y | 5Y -26.9% | -31.0%

Dil EPS 3Y | 5Y 23.8% | 18.7%

FCF 3Y | 5Y -2.1% | 7.2%

Returns

ROA -46.3%

ROE -288.4%

ROIC -49.0%

Financial Health

Net Cash

$111.4M

Current Ratio 8.13

Interest Coverage -7.27

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etri...

Sector Healthcare

Industry Biotechnology

Employees 38

IPO Date May 8, 2019

Website www.milestonepharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$4.50

Upside

+389.13%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞